|
1
|
Madsen JR, Laursen LS and Lauritsen K:
Chronic inflammatory bowel disease-current status. Ugeskr Laeger.
154:2243–2250. 1992.(In Danish). PubMed/NCBI
|
|
2
|
Ng SC, Zeng Z, Niewiadomski O, Tang W,
Bell S, Kamm MA, Hu P, de Silva HJ, Niriella MA, Udara WS, et al:
Early course of inflammatory bowel disease in a population-based
inception cohort study from 8 countries in Asia and Australia.
Gastroenterology. 150:82–95. e3; quiz e13-e14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kjellev S: The trefoil factor family-small
peptides with multiple functionalities. Cell Mol Life Sci.
66:1350–1369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stanczyk J, Pedrioli DM, Brentano F,
Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S and Kyburz
D: Altered expression of MicroRNA in synovial fibroblasts and
synovial tissue in rheumatoid arthritis. Arthritis Rheum.
58:1001–1009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y,
Huang X, Zhou H, de Vries N, Tak PP, et al: MicroRNA-146A
contributes to abnormal activation of the type I interferon pathway
in human lupus by targeting the key signaling proteins. Arthritis
Rheum. 60:1065–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan Z, Randall G, Fan J, Camoretti-Mercado
B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF,
Nicolae D and Ober C: Allele-specific targeting of microRNAs to
HLA-G and risk of asthma. Am J Hum Genet. 81:829–834. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fasseu M, Tréton X, Guichard C, Pedruzzi
E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC,
Moreau R, et al: Identification of restricted subsets of mature
microRNA abnormally expressed in inactive colonic mucosa of
patients with inflammatory bowel disease. PLoS One. 5:pii:
e131602010. View Article : Google Scholar
|
|
9
|
Sheedy FJ, Palsson-McDermott E, Hennessy
EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y and O'Neill
LA: Negative regulation of TLR4 via targeting of the
proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat
Immunol. 11:141–147. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
McKenna LB, Schug J, Vourekas A, McKenna
JB, Bramswig NC, Friedman JR and Kaestner KH: MicroRNAs control
intestinal epithelial differentiation, architecture, and barrier
function. Gastroenterology. 139:1654–1664, e1. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye D, Guo S, Al-Sadi R and Ma TY: MicroRNA
regulation of intestinal epithelial tight junction permeability.
Gastroenterology. 141:1323–1333. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bansal A, Lee IH, Hong X, Anand V, Mathur
SC, Gaddam S, Rastogi A, Wani SB, Gupta N, Visvanathan M, et al:
Feasibility of microRNAs as biomarkers for Barrett's Esophagus
progression: A pilot cross-sectional, phase 2 biomarker study. Am J
Gastroenterol. 106:1055–1063. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Olaru AV, Selaru FM, Mori Y, Vazquez C,
David S, Paun B, Cheng Y, Jin Z, Yang J, Agarwal R, et al: Dynamic
changes in the expression of MicroRNA-31 during inflammatory bowel
disease-associated neoplastic transformation. Inflamm Bowel Dis.
17:221–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanaan Z, Rai SN, Eichenberger MR, Barnes
C, Dworkin AM, Weller C, Cohen E, Roberts H, Keskey B, Petras RE,
et al: Differential microRNA expression tracks neoplastic
progression in inflammatory bowel disease-associated colorectal
cancer. Hum Mutat. 33:551–560. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu F, Guo NJ, Tian H, Marohn M, Gearhart
S, Bayless TM, Brant SR and Kwon JH: Peripheral blood microRNAs
distinguish active ulcerative colitis and Crohn's disease. Inflamm
Bowel Dis. 1:241–250. 2011. View Article : Google Scholar
|
|
17
|
Henderson P and Wilson DC: The rising
incidence of paediatric-onset inflammatory bowel disease. Arch Dis
Child. 97:585–586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XQ, Zhang Y, Xu CD, Jiang LR, Huang
Y, Du HM and Wang XJ: Inflammatory bowel disease in Chinese
children: A multicenter analysis over a decade from Shanghai.
Inflamm bowel Dis. 19:423–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Z, Liu H, Yang Z, Shao D, Zhang W, Ren
Y, Sun B, Lin J, Xu M and Nie S: Intestinal trefoil factor
activates the PI3K/Akt signaling pathway to protect gastric mucosal
epithelium from damage. Int J Oncol. 45:1123–1132. 2014.PubMed/NCBI
|
|
20
|
Kindon H, Pothoulakis C, Thim L,
Lynch-Devaney K and Podolsky DK: Trefoil peptide protection of
intestinal epithelial barrier function: Cooperative interaction
with mucin glycoprotein. Gastroenterology. 109:516–523. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marchbank T, Cox HM, Goodlad RA, Giraud
AS, Moss SF, Poulsom R, Wright NA, Jankowski J and Playford RJ:
Effect of ectopic expression of rat trefoil factor family 3
(intestinal trefoil factor) in the jejunum of transgenic mice. J
Biol Chem. 276:24088–24096. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mashimo H, Wu DC, Podolsky DK and Fishman
MC: Impaired defense of intestinal mucosa in mice lacking
intestinal trefoil factor. Science. 274:262–265. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu LF, Teng X, Guo J and Sun M: Protective
effect of intestinal trefoil factor on injury of intestinal
epithelial tight junction induced by platelet activating factor.
Inflammation. 35:308–315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu LF, Xu C, Mao ZQ, Teng X, Ma L and Sun
M: Disruption of the F-actin cytoskeleton and monolayer barrier
integrity induced by PAF and the protective effect of ITF on
intestinal epithelium. Arch Pharm Res. 34:245–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi
Y, Wu X, Cheng L, Ma C, Xia J and Wang Z: Curcumin inhibits cell
growth and invasion through up-regulation of miR-7 in pancreatic
cancer cells. Toxicol Lett. 231:82–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu K, Chen Z, Qin C and Song X: miR-7
inhibits colorectal cancer cell proliferation and induces apoptosis
by targeting XRCC2. Onco Targets Ther. 7:325–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen HT, Dalmasso G, Yan Y, Laroui H,
Dahan S, Mayer L, Sitaraman SV and Merlin D: MicroRNA-7 modulates
CD98 expression during intestinal epithelial cell differentiation.
J Biol Chem. 285:1479–1489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pekow JR and Kwon JH: MicroRNAs in
inflammatory bowel disease. Inflamm Bowel Dis. 18:187–193. 2012.
View Article : Google Scholar : PubMed/NCBI
|
